[PDF] from hematologylibrary.orgRK Wadhera, RA Kyle, DR Larson… - …, 2011 - bloodjournal.hematologylibrary.org Page 1. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma Rishi K. Wadhera, MD 1 ... distinct from the original clone referred to as secondary monoclonal gammopathy of ... View as HTML
VH Jimenez-Zepeda, RL Heilman, RA Engel… - …, 2011 - journals.lww.com Background. Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic plasma cell proliferative disorder with a lifelong risk of progression to multiple myeloma or another plasma cell dyscrasia. Despite a high incidence in the general population and an ... Related articles - All 4 versions
A Zingone… - Seminars in hematology, 2011 - ncbi.nlm.nih.gov Monoclonal gammopathy of undetermined significance (MGUS), including immunoglobulin light chain only MGUS, is an age-dependent premalignant tumor that is present in about 4% of Caucasian individuals over the age of 50 years. It is comprised of two different kinds of tumors: about ... All 4 versions
RA Kyle, A Dispenzieri, S Kumar… - … myeloma & leukemia, 2011 - CIG Media Group Abstract Monoclonal gammopathy of undetermined significance of IgM class (IgM MGUS) was diagnosed in 213 Mayo Clinic patients who were residents of 11 counties in Southeastern Minnesota from 1960 to 1994. During long-term follow-up 29 (14%) developed non-Hodgkin ... Cited by 3 - Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
